SEARCH LISTED COMPANY

Any AUS or NZ company

BROWSE

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY

SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

SIRTEX MEDICAL LIMITED (SRX)

Click here for free access to this company's:
ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 

Shareholder links

Our website ranking of SRX: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Link Market Services, Rhodes Corporate Park, 1A Homebush Bay Drive, Rhodes NSW 2138
Tel : +61 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: Level 33, 101 Miller Street, NORTH SYDNEY, NSW, AUSTRALIA, 2060
Tel:  (02) 9964 8400 Fax: (02) 9964 8410

Date first listed: 24/08/2000
Company Secretary: Darren Smith
Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Research, develop, and commercialise effective treatments for liver cancer using small particle technology

delisted from the close of trading on Monday, 24 September 2018, pursuant to Listing rule 17.11.

24/09/2018

we understand Grand Pharma Sphere (Australia Bidco) Pty Ltd, an entity owned by CDH Genetech Limited and China Grand Pharmaceutical and Healthcare Holdings Limited acquired all of the shares in SRX for the cash consideration of A$33.60 per share

24/09/2018

The scheme of arrangement by which Grand Pharma Sphere, an entity owned by CDH Genetech and China Grand Pharmaceutical and Healthcare Holdings would acquire all shares of Sirtex was implemented today.

20/09/2018

The securities of Sirtex Medical Limited will be suspended from quotation at the close of trading today, Thursday, 13 September 2018, in accordance with Listing Rule 17.2, following lodgement of the Federal Court of Australia orders with the Australian Securities and Investments Commission approving the scheme of arrangement by which Grand Pharma Sphere (Australia Bidco) Pty Ltd, an entity owned by CDH Genetech Limited and China Grand Pharmaceutical and Healthcare Holdings Limited will acquire all of the issued shares in SRX.

13/09/2018

listed entity carried for record purposes only

01/07/2004

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    25/08/2017Katherine Woodthorpe2,000$14.800$29,600
    23/08/2017Neville Mitchell6,000$14.566$87,397
    26/10/2016Gilman Wong74,968$28.484$2,135,378
    28/09/2015Richard HillOn market3,000$33.438$100,314
    19/07/2013Gilman WongOn market30,106$11.848$356,684

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Nigel LangeCEO13/01/2017
    Darren SmithCFO26/02/2009
    Katherine WoodthorpeIndependent Director22/09/2015
    Neville MitchellIndependent Director10/04/2017
    Andrew McLeanExecutive Director, CEO05/06/2017

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    John EadyNon Exec Chairman01/03/200520/09/2018
    Helen KurincicIndependent Director13/09/201720/09/2018
    Grant BoyceNon Exec Director19/12/200220/09/2018
    Richard HillNon Exec Chairman, Independent Director01/09/200428/10/2017
    Gilman WongCEO, Director01/03/200513/01/2017
    Bruce GrayNon Exec Director01/04/199723/01/2007
    Charles RowlandExecutive Director, Executive28/06/200326/10/2005
    Michael PanaccioNon Exec Director01/02/199829/07/2005
    Colin SuttonCEO01/03/200030/06/2003
    Christopher RobertsNon Exec Chairman01/03/200019/12/2002

    Date of first appointment, title may have changed.